https://stock.noler.com/us/stock/replicel-life-sciences-inc https://stock.noler.com/us/stock/replicel-life-sciences-inc/accounting-profit https://stock.noler.com/us/stock/replicel-life-sciences-inc/activist-13d-13g-form-sc-13d https://stock.noler.com/us/stock/replicel-life-sciences-inc/additional-paidin-capital https://stock.noler.com/us/stock/replicel-life-sciences-inc/adjusted-weighted-average-shares https://stock.noler.com/us/stock/replicel-life-sciences-inc/adjustments-for-depreciation-and-amortisation-expense https://stock.noler.com/us/stock/replicel-life-sciences-inc/adjustments-for-increase-decrease-in-trade-account-payable https://stock.noler.com/us/stock/replicel-life-sciences-inc/adjustments-for-share-based-payments https://stock.noler.com/us/stock/replicel-life-sciences-inc/adjustments-for-unrealised-foreign-exchange-losses-gains https://stock.noler.com/us/stock/replicel-life-sciences-inc/amended-reports-20-f https://stock.noler.com/us/stock/replicel-life-sciences-inc/applicable-tax-rate https://stock.noler.com/us/stock/replicel-life-sciences-inc/average-exercise-price-of-other-equity-instruments-exercisable-in-share-based-payment-arrangement https://stock.noler.com/us/stock/replicel-life-sciences-inc/average-exercise-price-of-share-options-exercisable-in-share-based-payment-arrangement https://stock.noler.com/us/stock/replicel-life-sciences-inc/average-exercise-price-of-share-options-exercisable-in-share-based-payment-arrangement-2019 https://stock.noler.com/us/stock/replicel-life-sciences-inc/average-exercise-price-of-share-options-expired-in-share-based-payment-arrangement https://stock.noler.com/us/stock/replicel-life-sciences-inc/average-exercise-price-of-share-options-expired-in-share-based-payment-arrangement-2019 https://stock.noler.com/us/stock/replicel-life-sciences-inc/average-exercise-price-of-share-options-forfeited-in-share-based-payment-arrangement https://stock.noler.com/us/stock/replicel-life-sciences-inc/average-exercise-price-of-share-options-forfeited-in-share-based-payment-arrangement-2019 https://stock.noler.com/us/stock/replicel-life-sciences-inc/average-exercise-price-of-share-options-granted-in-share-based-payment-arrangement https://stock.noler.com/us/stock/replicel-life-sciences-inc/average-exercise-price-of-share-options-granted-in-share-based-payment-arrangement-2019 https://stock.noler.com/us/stock/replicel-life-sciences-inc/average-exercise-price-of-share-options-outstanding-in-share-based-payment-arrangement https://stock.noler.com/us/stock/replicel-life-sciences-inc/average-exercise-price-of-share-options-outstanding-in-share-based-payment-arrangement-2019 https://stock.noler.com/us/stock/replicel-life-sciences-inc/basic-and-diluted-earnings-loss-per-share https://stock.noler.com/us/stock/replicel-life-sciences-inc/borrowings-interest-rate https://stock.noler.com/us/stock/replicel-life-sciences-inc/cash-and-cash-equivalents https://stock.noler.com/us/stock/replicel-life-sciences-inc/cash-flows-from-used-in-decrease-increase-in-shortterm-deposits-and-investments https://stock.noler.com/us/stock/replicel-life-sciences-inc/cash-flows-from-used-in-financing-activities https://stock.noler.com/us/stock/replicel-life-sciences-inc/cash-flows-from-used-in-investing-activities https://stock.noler.com/us/stock/replicel-life-sciences-inc/cash-flows-from-used-in-operating-activities https://stock.noler.com/us/stock/replicel-life-sciences-inc/cash-on-hand https://stock.noler.com/us/stock/replicel-life-sciences-inc/clinical-trials https://stock.noler.com/us/stock/replicel-life-sciences-inc/cover-page-shares-outstanding https://stock.noler.com/us/stock/replicel-life-sciences-inc/current-assets https://stock.noler.com/us/stock/replicel-life-sciences-inc/current-contract-assets https://stock.noler.com/us/stock/replicel-life-sciences-inc/current-contract-liabilities https://stock.noler.com/us/stock/replicel-life-sciences-inc/current-liabilities https://stock.noler.com/us/stock/replicel-life-sciences-inc/current-prepaid-expenses https://stock.noler.com/us/stock/replicel-life-sciences-inc/current-tax-assets-current https://stock.noler.com/us/stock/replicel-life-sciences-inc/deferred-tax-expense-income https://stock.noler.com/us/stock/replicel-life-sciences-inc/deferred-tax-liability-asset https://stock.noler.com/us/stock/replicel-life-sciences-inc/derivative-financial-liabilities https://stock.noler.com/us/stock/replicel-life-sciences-inc/description-of-expected-volatility-share-options-granted https://stock.noler.com/us/stock/replicel-life-sciences-inc/description-of-option-life-share-options-granted https://stock.noler.com/us/stock/replicel-life-sciences-inc/description-of-risk-free-interest-rate-share-options-granted https://stock.noler.com/us/stock/replicel-life-sciences-inc/diluted-earnings-loss-per-share https://stock.noler.com/us/stock/replicel-life-sciences-inc/directors-remuneration-expense https://stock.noler.com/us/stock/replicel-life-sciences-inc/dividend-payables https://stock.noler.com/us/stock/replicel-life-sciences-inc/dividends-paid-ordinary-shares https://stock.noler.com/us/stock/replicel-life-sciences-inc/dividends-received https://stock.noler.com/us/stock/replicel-life-sciences-inc/equity https://stock.noler.com/us/stock/replicel-life-sciences-inc/equity-and-liabilities https://stock.noler.com/us/stock/replicel-life-sciences-inc/exercise-price-share-options-granted https://stock.noler.com/us/stock/replicel-life-sciences-inc/exercise-price-share-options-granted-2019 https://stock.noler.com/us/stock/replicel-life-sciences-inc/expected-dividend-share-options-granted https://stock.noler.com/us/stock/replicel-life-sciences-inc/financial-liabilities https://stock.noler.com/us/stock/replicel-life-sciences-inc/form-d-other https://stock.noler.com/us/stock/replicel-life-sciences-inc/gains-losses-on-exchange-differences-on-translation-recognised-in-profit-or-loss https://stock.noler.com/us/stock/replicel-life-sciences-inc/general-and-administrative-expense https://stock.noler.com/us/stock/replicel-life-sciences-inc/income-tax-expense https://stock.noler.com/us/stock/replicel-life-sciences-inc/increase-decrease-in-cash-and-cash-equivalents https://stock.noler.com/us/stock/replicel-life-sciences-inc/increase-decrease-in-number-of-ordinary-shares-issued https://stock.noler.com/us/stock/replicel-life-sciences-inc/increase-decrease-in-number-of-shares-outstanding https://stock.noler.com/us/stock/replicel-life-sciences-inc/increase-decrease-through-exercise-of-warrants-equity https://stock.noler.com/us/stock/replicel-life-sciences-inc/increase-decrease-through-share-based-payment-transactions https://stock.noler.com/us/stock/replicel-life-sciences-inc/incremental-fair-value-granted-modified-share-based-payment-arrangements https://stock.noler.com/us/stock/replicel-life-sciences-inc/interest-expense https://stock.noler.com/us/stock/replicel-life-sciences-inc/investment-income https://stock.noler.com/us/stock/replicel-life-sciences-inc/issue-of-equity https://stock.noler.com/us/stock/replicel-life-sciences-inc/issued-capital https://stock.noler.com/us/stock/replicel-life-sciences-inc/key-management-personnel-compensation https://stock.noler.com/us/stock/replicel-life-sciences-inc/key-management-personnel-compensation-share-based-payment https://stock.noler.com/us/stock/replicel-life-sciences-inc/key-management-personnel-compensation-shortterm-employee-benefits https://stock.noler.com/us/stock/replicel-life-sciences-inc/late-filing-notices-nt-20-f https://stock.noler.com/us/stock/replicel-life-sciences-inc/licence-fee-income https://stock.noler.com/us/stock/replicel-life-sciences-inc/longterm-borrowings https://stock.noler.com/us/stock/replicel-life-sciences-inc/noncurrent-contract-assets https://stock.noler.com/us/stock/replicel-life-sciences-inc/noncurrent-contract-liabilities https://stock.noler.com/us/stock/replicel-life-sciences-inc/number-of-outstanding-share-options https://stock.noler.com/us/stock/replicel-life-sciences-inc/number-of-share-options-exercisable-in-share-based-payment-arrangement https://stock.noler.com/us/stock/replicel-life-sciences-inc/number-of-share-options-expired-in-share-based-payment-arrangement https://stock.noler.com/us/stock/replicel-life-sciences-inc/number-of-share-options-forfeited-in-share-based-payment-arrangement https://stock.noler.com/us/stock/replicel-life-sciences-inc/number-of-share-options-granted-in-share-based-payment-arrangement https://stock.noler.com/us/stock/replicel-life-sciences-inc/number-of-shares-issued https://stock.noler.com/us/stock/replicel-life-sciences-inc/number-of-shares-outstanding https://stock.noler.com/us/stock/replicel-life-sciences-inc/other-current-payables https://stock.noler.com/us/stock/replicel-life-sciences-inc/other-fee-and-commission-expense https://stock.noler.com/us/stock/replicel-life-sciences-inc/other-tax-effects-for-reconciliation-between-accounting-profit-and-tax-expense-income https://stock.noler.com/us/stock/replicel-life-sciences-inc/patents-active https://stock.noler.com/us/stock/replicel-life-sciences-inc/patents-pending https://stock.noler.com/us/stock/replicel-life-sciences-inc/payments-for-share-issue-costs https://stock.noler.com/us/stock/replicel-life-sciences-inc/proceeds-from-exercise-of-warrants https://stock.noler.com/us/stock/replicel-life-sciences-inc/proceeds-from-government-grants-classified-as-financing-activities https://stock.noler.com/us/stock/replicel-life-sciences-inc/proceeds-from-issue-of-preference-shares https://stock.noler.com/us/stock/replicel-life-sciences-inc/proceeds-from-issuing-shares https://stock.noler.com/us/stock/replicel-life-sciences-inc/proceeds-from-noncurrent-borrowings https://stock.noler.com/us/stock/replicel-life-sciences-inc/profit-loss https://stock.noler.com/us/stock/replicel-life-sciences-inc/profit-loss-from-operating-activities https://stock.noler.com/us/stock/replicel-life-sciences-inc/property-plant-and-equipment https://stock.noler.com/us/stock/replicel-life-sciences-inc/purchase-of-property-plant-and-equipment-classified-as-investing-activities https://stock.noler.com/us/stock/replicel-life-sciences-inc/research-and-development https://stock.noler.com/us/stock/replicel-life-sciences-inc/retained-earnings https://stock.noler.com/us/stock/replicel-life-sciences-inc/revenue https://stock.noler.com/us/stock/replicel-life-sciences-inc/revenue-from-government-grants https://stock.noler.com/us/stock/replicel-life-sciences-inc/sec-comment-letters-corresp https://stock.noler.com/us/stock/replicel-life-sciences-inc/sec-comment-letters-upload https://stock.noler.com/us/stock/replicel-life-sciences-inc/sec-filings-20-f https://stock.noler.com/us/stock/replicel-life-sciences-inc/sec-filings-20fr12g https://stock.noler.com/us/stock/replicel-life-sciences-inc/sec-filings-6-k https://stock.noler.com/us/stock/replicel-life-sciences-inc/sec-filings-ct-order https://stock.noler.com/us/stock/replicel-life-sciences-inc/sec-filings-sc-14f1 https://stock.noler.com/us/stock/replicel-life-sciences-inc/secondary-offerings-form-s-8 https://stock.noler.com/us/stock/replicel-life-sciences-inc/secondary-offerings-form-s-8-pos https://stock.noler.com/us/stock/replicel-life-sciences-inc/services-received-related-party-transactions https://stock.noler.com/us/stock/replicel-life-sciences-inc/sga-expense https://stock.noler.com/us/stock/replicel-life-sciences-inc/share-issue-related-cost https://stock.noler.com/us/stock/replicel-life-sciences-inc/shortterm-investments-classified-as-cash-equivalents https://stock.noler.com/us/stock/replicel-life-sciences-inc/tax-effect-of-expense-not-deductible-in-determining-taxable-profit-tax-loss https://stock.noler.com/us/stock/replicel-life-sciences-inc/tax-expense-income-at-applicable-tax-rate https://stock.noler.com/us/stock/replicel-life-sciences-inc/total-assets https://stock.noler.com/us/stock/replicel-life-sciences-inc/total-liabilities https://stock.noler.com/us/stock/replicel-life-sciences-inc/trade-and-other-current-payables https://stock.noler.com/us/stock/replicel-life-sciences-inc/trade-and-other-payables-to-related-parties https://stock.noler.com/us/stock/replicel-life-sciences-inc/transfers-of-research-and-development-from-entity-related-party-transactions https://stock.noler.com/us/stock/replicel-life-sciences-inc/unused-tax-losses-for-which-no-deferred-tax-asset-recognised https://stock.noler.com/us/stock/replicel-life-sciences-inc/value-at-risk https://stock.noler.com/us/stock/replicel-life-sciences-inc/weighted-average-share-price